Companies

CVS HEALTH Corp

CVS · CIK 0000064803 · operating

$79.90+2.42%Last updated Feb 27, 10:05 PM

Key Statistics

Valuation

Market Cap$101.65B
P/E57.48
Fwd P/E9.77
PEG
P/S0.25
P/B1.35
EV/EBITDA11.70
EV/Rev0.43

Profitability

Gross Margin
Op. Margin1.16%
Net Margin0.44%
ROE2.35%
ROA0.70%
FCF Margin1.94%

Financial Health

Current Ratio0.84
Debt/Equity2.37
Free Cash Flow$7.81B
Div. Yield3.33%

Growth & Other

Revenue Growth7.85%
EPS Growth-62.02%
Beta0.50
52W High$85.15
52W Low$58.35

About CVS HEALTH Corp

CVS Health operates as an integrated healthcare company serving the United States through three primary segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products including medical, pharmacy, dental, and behavioral health plans, alongside Medicare Advantage, Medicare Supplement, and Medicaid managed care services. The Health Services segment provides pharmacy benefit management solutions, including plan design, formulary management, specialty pharmacy, mail order services, and clinical disease management programs. The Pharmacy & Consumer Wellness segment operates retail pharmacy locations, online pharmacy platforms, specialty pharmacies, and infusion services while selling prescription medications, over-the-counter drugs, and consumer health products.

The company serves a diverse customer base spanning employer groups, individuals, health plans, health care providers, government-sponsored plans, and unions. CVS Health was founded in 1963 and incorporated in Delaware, with headquarters in Woonsocket, Rhode Island. The organization operates with approximately 219,000 full-time employees and maintains significant scale across the U.S. healthcare market, combining insurance operations with extensive retail pharmacy networks and pharmacy benefit management capabilities to address multiple points in the healthcare value chain.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$1.39$1.40-62.0%
2024$3.66$3.67-43.4%
2023$6.47$6.49+106.1%
2022$3.14$3.16-47.2%
2021$5.95$6.00+9.0%
2020$5.46$5.48+310.5%
2019$1.33$1.34+459.5%
2018$-0.37$-0.37-111.5%
2017$3.22$3.23+102.5%
2016$1.59$1.60+18.7%
2015$1.34$1.35+17.5%
2014$1.14$1.15+8.6%
2013$1.05$1.06+16.7%
2012$0.90$0.91+11.1%
2011$0.81$0.82+8.0%
2010$0.75$0.75-70.6%
2009$2.55$2.58

Annual Reports (10-K) · 9 filings

Report DateFiledAccession Number
2025-12-312026-02-100000064803-26-000010SEC ↗
2024-12-312025-02-120000064803-25-000007SEC ↗
2023-12-312024-02-070000064803-24-000007SEC ↗
2022-12-312023-02-080000064803-23-000009SEC ↗
2021-12-312022-02-090000064803-22-000008SEC ↗
2020-12-312021-02-160000064803-21-000011SEC ↗
2019-12-312020-02-180000064803-20-000007SEC ↗
2018-12-312019-02-280000064803-19-000013SEC ↗
2017-12-312018-02-140001558370-18-000707SEC ↗